Sigma-Aldrich gets new EU charges over false information in merger review (update*)
German biotech company Sigma-Aldrich is the target of additional charges over alleged false information submitted to EU officials during a merger deal involving Merck KGaA. The European Commission said today it had...To view the full article, register now.
Already a subscriber? Click here to view full article